Assays for hepatitis B surface antigen (HBsAg) are the most frequently ... testing and also to ascertain likely cause of weakly positive (grayzone) results. Results During the 17 month study ...

Spontaneous loss of hepatitis B e antigen (HBeAg) followed by seroconversion ... regimen and timing of therapy for a patient with HBeAg-positive hepatitis. Accreditation: Tufts University School ...

Study: AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus ... system in people who are either positive for the HBV surface antigen (HBsAg) or HBV core antibody ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...

For patients at high risk of hepatitis B reactivation ... antibodies to HBV surface Ag (anti-HBs), and HBV total core Ag (anti-HBc). Those with positive anti-HBc are at risk for HBVr.

Alliance Global Partners analyst James Molloy lowered the firm’s price target on Barinthus Biotherapeutics (BRNS) to $6 from $7.50 and keeps a ...

The trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.

For patients at high risk of hepatitis B reactivation ... antibodies to HBV surface Ag (anti-HBs), and HBV total core Ag (anti-HBc). Those with positive anti-HBc are at risk for HBVr.

bepirovirsen at a dose of 300 mg per week over 24 weeks resulted in sustained hepatitis B surface antigen (HBsAg) and HBV DNA loss to below the limits of detection in 9% to 10% of participants ...

Blood tests for hepatitis A virus IgM, hepatitis B virus core IgM, hepatitis B virus surface antigen, and hepatitis ... test for treponemal antibodies was positive, and a rapid plasma reagin ...

The Nasdaq is one of the top three most-followed stock market indices in the United States, comprising over 2,500 stocks.